1 January - 30 June (unaudited)
|
kEUR |
Note |
H1 2022 |
H1 2021 |
|
|
|
|
|
|
Result for the period |
|
10,247 |
24,623 |
|
|
|
|
|
|
Other comprehensive income to be reclassified to profit or loss in subsequent periods |
|
|
|
|
Exchange differences on translation of foreign operations, net of tax |
|
8,840 |
1,553 |
|
Net other comprehensive income to be reclassified to profit or loss in subsequent periods |
|
8,840 |
1,553 |
|
|
|
|
|
|
Other comprehensive income not to be reclassified to profit or loss in subsequent periods |
|
|
|
|
Remeasurement gain / (loss) on defined benefit plans |
|
10,028 |
3,877 |
|
Income tax effect |
|
-2,338 |
-889 |
|
Net other comprehensive income not to be reclassified to profit or loss in subsequent periods |
|
7,690 |
2,988 |
|
Other comprehensive result for the period, net of taxes |
|
16,530 |
4,541 |
|
|
|
|
|
|
Total comprehensive result for the period, net of taxes |
|
26,777 |
29,164 |
|
|
|
|
|
|
Attributable to shareholders of PolyPeptide Group AG |
|
26,777 |
29,164 |